| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 286 |
| 1 | ACETAMINOPHEN | 176 |
| 2 | RIBAVIRIN | 174 |
| 3 | RIFAXIMIN | 171 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 156 |
| 5 | TACROLIMUS OINTMENT 0.1% | 156 |
| 6 | AMBRISENTAN | 150 |
| 7 | MACITENTAN | 145 |
| 8 | ACETAMINOPHEN 500MG | 133 |
| 9 | SOFOSBUVIR | 133 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITISINONE | 118 | 0.1234 |
| 1 | MARALIXIBAT CHLORIDE | 103 | 0.1028 |
| 2 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.1000 |
| 3 | ODEVIXIBAT | 36 | 0.0905 |
| 4 | NEDOSIRAN | 1 | 0.0833 |
| 5 | GLYCERIN, LIDOCAINE, PETROLATUM, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0556 |
| 6 | CITRIC ACID AND SODIUM CITRATE | 1 | 0.0417 |
| 7 | HEPATITIS B IMMUNE GLOBULIN (HUMAN) | 2 | 0.0392 |
| 8 | LUMASIRAN | 13 | 0.0337 |
| 9 | BULEVIRTIDE | 3 | 0.0312 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 118 | 0.1430 |
| 1 | Ileal Bile Acid Transporter Inhibitor [EPC] | 36 | 0.0791 |
| 2 | Human Immunoglobulin [EPC] | 2 | 0.0392 |
| 3 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 12 | 0.0159 |
| 4 | Rifamycin Antibacterial [EPC] | 210 | 0.0058 |
| 5 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 201 | 0.0038 |
| 6 | Bile Acid [EPC] | 88 | 0.0038 |
| 7 | Aldehyde Dehydrogenase Inhibitor [EPC] | 3 | 0.0026 |
| 8 | Vitamin K [EPC] | 20 | 0.0023 |
| 9 | Vasopressin V2 Receptor Antagonist [EPC] | 34 | 0.0023 |